Loring Wolcott & Coolidge Fiduciary Advisors’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-306
| Closed | -$4.51K | – | 573 |
|
2023
Q4 | $4.51K | Hold |
306
| – | – | ﹤0.01% | 523 |
|
2023
Q3 | $2.87K | Hold |
306
| – | – | ﹤0.01% | 577 |
|
2023
Q2 | $3.08K | Sell |
306
-230
| -43% | -$2.31K | ﹤0.01% | 598 |
|
2023
Q1 | $5.04K | Hold |
536
| – | – | ﹤0.01% | 545 |
|
2022
Q4 | $6.55K | Hold |
536
| – | – | ﹤0.01% | 514 |
|
2022
Q3 | $7K | Hold |
536
| – | – | ﹤0.01% | 543 |
|
2022
Q2 | $11K | Hold |
536
| – | – | ﹤0.01% | 539 |
|
2022
Q1 | $14K | Hold |
536
| – | – | ﹤0.01% | 533 |
|
2021
Q4 | $15K | Hold |
536
| – | – | ﹤0.01% | 562 |
|
2021
Q3 | $17K | Hold |
536
| – | – | ﹤0.01% | 534 |
|
2021
Q2 | $19K | Buy |
+536
| New | +$19K | ﹤0.01% | 543 |
|
2021
Q1 | – | Sell |
-536
| Closed | -$16K | – | 428 |
|
2020
Q4 | $16K | Hold |
536
| – | – | ﹤0.01% | 527 |
|
2020
Q3 | $15K | Hold |
536
| – | – | ﹤0.01% | 490 |
|
2020
Q2 | $11K | Hold |
536
| – | – | ﹤0.01% | 493 |
|
2020
Q1 | $12K | Hold |
536
| – | – | ﹤0.01% | 523 |
|
2019
Q4 | $16K | Sell |
536
-1,580
| -75% | -$47.2K | ﹤0.01% | 555 |
|
2019
Q3 | $56K | Hold |
2,116
| – | – | ﹤0.01% | 399 |
|
2019
Q2 | $72K | Buy |
2,116
+305
| +17% | +$10.4K | ﹤0.01% | 364 |
|
2019
Q1 | $58K | Buy |
+1,811
| New | +$58K | ﹤0.01% | 390 |
|